These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 1829068

  • 1. Hepatobiliary toxicity of 5-fluoro-2'-deoxyuridine. Intra-arterial versus portal venous routes of infusion.
    Andrews JC, Kuntsen C, Terio P, Priescorn D, Ensminger WD.
    Invest Radiol; 1991 May; 26(5):461-4. PubMed ID: 1829068
    [Abstract] [Full Text] [Related]

  • 2. Floxuridine-associated sclerosing cholangitis. A dog model.
    Andrews JC, Knol J, Wollner I, Knutsen C, Smith P, Prieskorn D, Ensminger W.
    Invest Radiol; 1989 Jan; 24(1):47-51. PubMed ID: 2521845
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Toxicities and complications of implanted pump hepatic arterial and intravenous floxuridine infusion.
    Hohn DC, Rayner AA, Economou JS, Ignoffo RJ, Lewis BJ, Stagg RJ.
    Cancer; 1986 Feb 01; 57(3):465-70. PubMed ID: 2935242
    [Abstract] [Full Text] [Related]

  • 5. Chronic infusion of 5-fluoro-2'-deoxyuridine (5-FUDR) into the hepatic artery of the dog.
    Khazei AM, Patel DD, Morgenthaler FR, MacDonald AJ, Sanadizadeh SM, Watkins E.
    J Surg Res; 1970 Aug 01; 10(8):343-52. PubMed ID: 4193563
    [No Abstract] [Full Text] [Related]

  • 6. The effects on toxicity of circadian patterning of continuous hepatic artery infusion.
    Kemeny MM, Alava G, Oliver JM, Smith FB.
    HPB Surg; 1992 Apr 01; 5(3):185-93; discussion 193-4. PubMed ID: 1387318
    [Abstract] [Full Text] [Related]

  • 7. Hepatic arterial floxuridine and leucovorin for unresectable liver metastases from colorectal carcinoma. New dose schedules and survival update.
    Kemeny N, Seiter K, Conti JA, Cohen A, Bertino JR, Sigurdson ER, Botet J, Chapman D, Mazumdar M, Budd AJ.
    Cancer; 1994 Feb 15; 73(4):1134-42. PubMed ID: 8313315
    [Abstract] [Full Text] [Related]

  • 8. Toxicity study of hepatic artery infusion chemotherapy with massive dose FUDR in rats.
    Zeng ZS, Zhang ZF, Sigurdson ER.
    Surg Oncol; 1995 Jun 15; 4(3):147-55. PubMed ID: 7582187
    [Abstract] [Full Text] [Related]

  • 9. A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the Northern California Oncology Group trial.
    Hohn DC, Stagg RJ, Friedman MA, Hannigan JF, Rayner A, Ignoffo RJ, Acord P, Lewis BJ.
    J Clin Oncol; 1989 Nov 15; 7(11):1646-54. PubMed ID: 2530317
    [Abstract] [Full Text] [Related]

  • 10. [Sclerosing cholangitis after chemotherapy by continuous hepatic intra-arterial infusion of fluorodeoxyuridine].
    Bergmann JF, Rougier P, Liguory C, Zafrani ES, Métreau JM, Dhumeaux D.
    Gastroenterol Clin Biol; 1986 Feb 15; 10(2):177-9. PubMed ID: 2939001
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Complications of hepatic arterial infusion chemotherapy.
    Pozniak MA, Babel SG, Trump DL.
    Radiographics; 1991 Jan 15; 11(1):67-79. PubMed ID: 1825358
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Good tolerance to high-dose hepatic arterial infusion therapy.
    Wile AG, Kasimis BS, Iyer P, Kaneshiro CA, Moran EM.
    J Surg Oncol; 1986 Nov 15; 33(3):207-11. PubMed ID: 2945973
    [Abstract] [Full Text] [Related]

  • 15. Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial.
    Rougier P, Laplanche A, Huguier M, Hay JM, Ollivier JM, Escat J, Salmon R, Julien M, Roullet Audy JC, Gallot D.
    J Clin Oncol; 1992 Jul 15; 10(7):1112-8. PubMed ID: 1296590
    [Abstract] [Full Text] [Related]

  • 16. Hepatic artery versus portal vein and systemic infusion of fluorodeoxyuridine of rabbit VX-2 hepatic implants.
    Butler JA, Trezona TP, Nordestgaard A, State D.
    Am J Surg; 1989 Jan 15; 157(1):126-9. PubMed ID: 2521278
    [Abstract] [Full Text] [Related]

  • 17. Continuous intrahepatic infusion of floxuridine and leucovorin through an implantable pump for the treatment of hepatic metastases from colorectal carcinoma.
    Kemeny N, Cohen A, Bertino JR, Sigurdson ER, Botet J, Oderman P.
    Cancer; 1990 Jun 01; 65(11):2446-50. PubMed ID: 2140070
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Sclerosing cholangitis after continuous hepatic artery infusion of FUDR.
    Kemeny MM, Battifora H, Blayney DW, Cecchi G, Goldberg DA, Leong LA, Margolin KA, Terz JJ.
    Ann Surg; 1985 Aug 01; 202(2):176-81. PubMed ID: 3160313
    [Abstract] [Full Text] [Related]

  • 20. The effects on liver metastases of circadian patterned continuous hepatic artery infusion of FUDR.
    Kemeny MM, Alava G, Oliver JM.
    HPB Surg; 1994 Aug 01; 7(3):219-24. PubMed ID: 8155588
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.